MUC1-C regulates the SET1A/COMPASS-H3K4 methyltransferase complex via a distinct MUC1-C/NFκB pathway and integrates inflammatory signaling, epigenetic reprogramming and cancer stem cell state in the progression of triple-negative breast tumors. Here, NFKB1 is linked to cancer.